The 2024 guideline provides comprehensive recommendations for assessing cardiovascular disease risk and managing patients taking SGLT2-inhibitors. It also highlights the importance of judicious screening and evidence-based management of cardiovascular conditions before, during, and after noncardiac surgery.
A study published in JACC found that metal exposure is associated with progression of plaque buildup in the arteries, comparable to traditional risk factors like smoking and diabetes. The findings support considering metal exposure as a significant risk factor for atherosclerosis and cardiovascular disease.
The new European Society of Cardiology Guidelines recommend regular screenings for Peripheral Arterial Disease (PAD) to prevent complications. The guidelines also emphasize personalized treatment plans, including lifestyle changes, medication, and efficient blockage treatments.
The RESILIENCE clinical trial explores the effectiveness of remote ischemic conditioning to prevent cardiotoxicity in lymphoma patients undergoing anthracycline-based chemotherapy. The trial aims to reduce heart failure prevalence and improve quality of life for cancer survivors.
Researchers identified changes in the UBR4 gene as a key driver of fibromuscular dysplasia, a blood vessel disorder affecting up to five percent of adults. The discovery could lead to therapeutic approaches for the condition, particularly beneficial for women who account for 90% of cases.
A recent study published in the New England Journal of Medicine demonstrates the benefits of catheter-based mitral valve repair for patients with moderate to severe mitral regurgitation. The procedure showed a significant reduction in recurrent hospitalisations and improved quality of life after 12 months.
A recent study published in JACC: Clinical Electrophysiology found that quitting smoking can significantly lower the risk of atrial fibrillation, with former smokers having around 13% lower risk and current quitters having an 18% lower risk. The benefits of quitting are seen shortly after stopping smoking.
A study examines cardiac rehabilitation (CR) knowledge, attitudes, and practice (KAP) among patients with heart failure and cardiology healthcare providers. Key findings highlight the importance of proper knowledge and attitudes in effective self-management, indicating potential room for improvement.
A study at the European Society of Cardiology Congress found that an AI-enabled digital stethoscope helped doctors identify twice as many cases of pregnancy-related heart failure compared to a control group. The tool was 12 times more likely to flag heart pump weakness, leading to better diagnosis and potentially life-saving treatment.
Very intensive lipid-lowering therapy significantly regresses atheroma volume at the lesion level compared to statin therapy alone. This study found greater enlargement of the minimum lumen area and more frequent transition to stable plaque phenotypes with alirocumab treatment.
A nationwide study in Sweden reveals that short-term exposures to lower air temperature and cold spells are associated with an increased risk of myocardial infarction hospitalization after two-six days. Researchers found that this delay in hospitalizations suggests a delayed onset of cold-related impacts on MI risk.
A randomized, placebo-controlled trial found finerenone improved outcomes in patients with heart failure and mildly reduced or preserved ejection fraction. The drug also showed benefits regardless of the ejection fraction and even in patients on other approved therapies.
A blood test that measures three modifiable factors together can better predict cardiovascular risk than any marker used alone. The study found that inflammation is at least as important as cholesterol in predicting cardiovascular events.
Researchers found that digital consultations significantly improved medication adherence among heart failure patients, with 28% receiving optimal medication combinations after 12 weeks. The study also showed no negative impact on patient satisfaction or quality of life.
Researchers found that supplementing potassium only when levels fell below 3.6 mEq/L was noninferior to the current practice of maintaining higher levels, with no increase in adverse outcomes. Lower thresholds did not worsen clinical outcomes or dysrhythmias.
A novel low-dose 3-in-1 blood pressure pill (GMRx2) significantly reduces blood pressure in patients with uncontrolled hypertension. After six months treatment, the GMRx2 group achieved a 5.8mmHg lower systolic blood pressure compared to standard care.
Sacubitril/valsartan significantly reduced hospitalization for any reason, particularly in patients with a left ventricular ejection fraction below normal. Lower rates of cardiac and pulmonary hospitalizations were also observed in this patient population.
Treatment with prehospital pulse-dose glucocorticoid improved acute parameters, but did not reduce final infarct size after 3 months. The trial was likely underpowered due to smaller-than-anticipated final infarct sizes.
The new guidelines evaluate PAAD as part of the same cardiovascular system, acknowledging the interconnectedness between aortic and peripheral vascular diseases. The updated recommendations focus on chronic management, screening, and comprehensive treatment strategies to improve treatment outcomes.
A new substudy of the SELECT Trial found that semaglutide reduced rates of all-cause death, CV death, and non-CV death, including death from COVID-19, in patients with overweight or obesity and established cardiovascular disease without diabetes. Semaglutide also showed protective effects against COVID-19-related adverse events.
The new guidelines emphasize the importance of detecting non-obstructive coronary artery disease (NOCA/INOCA) caused by microcirculation dysfunction. A risk factor-weighted clinical likelihood model helps estimate pre-test likelihood, allowing for targeted testing and treatment. The guidelines also recommend invasive coronary functiona...
Continuation of renin-angiotensin system inhibitors before major noncardiac surgery was not associated with a higher rate of postoperative complications compared to discontinuation. The study aimed to investigate the impact of continued use of these medications on surgical outcomes.
A recent study led by Brigham and Women's Hospital found that semaglutide reduced deaths from cardiovascular disease and infections, including COVID-19, in obese and overweight patients. The study involved over 17,000 participants and showed a 19% lower overall death rate compared to placebo.
High levels of lipoprotein (a) found in 20-34% of Polish patients with heart disease or at risk. Lp(a) measurements may be crucial in preventing cardiovascular diseases and atherosclerosis progression.
Researchers at University of California San Diego have identified a novel mechanism of cardiac inflammation that may prevent heart failure after a heart attack. The borderzone, surrounding the infarcted area, is found to be a key region for this inflammation, with heart muscle cells playing a dominant role in initiating it.
TCT 2024 features groundbreaking research on minimally invasive techniques, pharmaceuticals, technologies, and devices to treat or prevent cardiovascular disease. The event showcases the latest advancements in interventional cardiology and offers a platform for clinicians to learn about new interventions and strategies.
Middle-income countries experience a disproportionate burden of cardiovascular disease, with higher mortality rates and significant disparities in prevention and management. The latest data from the European Society of Cardiology Atlas of Cardiology highlights the urgent need for effective strategies to address these inequalities.
Women undergoing cardiac surgery have a lower risk of developing postoperative atrial fibrillation compared to men, but are more vulnerable to its associated long-term morbidities. A study found that once atrial fibrillation develops, women have a significantly higher risk of mortality than men.
A new study found that interval exercise is better suited for men with low blood sugar levels, while continuous exercise is more effective for women. The research suggests that gender-specific recommendations should be considered when prescribing aerobic exercise to patients with type-1 diabetes.
Researchers analyzed echocardiographic reports from 225,163 patients to identify trends in AFMR. The study found that MV surgery significantly improves clinical outcomes and reduces mortality in elderly patients burdened with conditions like atrial fibrillation.
Researchers have designed a shunt that can expand when activated by light, potentially reducing the number of open-chest surgeries needed to accommodate growing children. In lab experiments, they found the shunt could be expanded incrementally, with adjustments customizable to each child.
A new heart MRI technique accurately estimates pressures inside the heart to predict heart failure risk in a general population. Key risk factors identified include age over 70, high blood pressure, obesity, alcohol consumption, and male gender.
The American College of Cardiology has released a new guidance on managing patients hospitalized for heart failure, recommending tailored therapy based on clinical trajectory. The updated Expert Consensus Decision Pathway aims to improve disease management and reduce mortality.
A UofL cardiologist is leading a Phase II clinical trial of a new stem cell therapy for heart failure, the first in the US to use intravenous delivery. The trial aims to determine whether one or multiple doses of mesenchymal stem cells improve health and quality of life for patients.
A team of scientists from Scripps Research has developed an AI tool that can diagnose heart conditions, including heart attacks, using just three electrodes and a simpler electrocardiogram technology. The tool was tested on 238 ECGs and showed accurate clinical assessment results similar to those from original 12-lead ECGs.
Scientists have developed a new way to 3D print materials that are strong enough to support human tissue and vary in shape and size. The breakthrough, known as CLEAR, helps pave the way toward a new generation of biomaterials for personalized implants and tissues.
A groundbreaking study analyzing 12 million deaths finds that stock market volatility is associated with a heightened risk of major adverse cardiovascular events (MACEs) and suicide. Daily stock returns show significant correlations with mortality risks, particularly among older adults, males, and those with lower education levels.
A new study found that an AI program generated explanations of heart test results in most cases, with 73% deemed suitable for patients without changes. The AI explanations were also rated as easy to understand by non-clinical participants, reducing worry in many cases.
The AHA PREVENT equations could reduce eligibility for statin and antihypertensive therapy among 15.8 million US adults due to lower atherosclerotic cardiovascular disease risk predictions. This change may impact treatment guidelines and recommendations.
A new scoring system has been developed to diagnose Heart Failure with Preserved Ejection Fraction (HFpEF), enabling more effective identification of patients. The HFpEF-ABA score model uses age, BMI, and atrial fibrillation to estimate the probability of HFpEF in individual patients.
A recent study published in ESC Heart Failure found that kidney dysfunction can be used as a criterion to stratify patients requiring implantable defibrillators. The research identified two key independent predictors for the risk of sudden cardiac death: left ventricular ejection fraction and estimated glomerular filtration rate.
Researchers from Osaka Metropolitan University developed a new scoring model using prehospital resuscitation data to predict neurological outcomes of patients with OHCA. The R-EDByUS score achieved high precision, enabling healthcare providers to make quick and accurate decisions upon hospital arrival.
Community disadvantage status affects hospital stroke care services, with disadvantaged hospitals having lower certification rates. Hospitals in most advantaged communities show higher likelihood of becoming stroke certified.
A nationwide study from University of Alabama at Birmingham compares two cardiovascular health metrics, Life’s Simple 7 and Life’s Essential 8, with the well-established Pooled Cohort Equation to determine their predictive values for mortality. The researchers found that PCEs outperformed LE8 and LS7 scores in mortality risk prediction.
A Mediterranean diet-based intervention has been shown to optimize cardiometabolic biomarkers in children and adolescents. The study found that this dietary approach can help improve cardiovascular health in young people, potentially reducing the risk of chronic diseases later in life.
Researchers developed an AI model to analyze heart MRI scans, which can save NHS time and resources. The model provides a complete analysis of the entire heart using a view that shows all four chambers, leading to faster and more accurate diagnosis of heart failure and other cardiac conditions.
A study by Michigan Medicine found that older women over 65 who require complex heart surgery are more likely to be treated at low-quality hospitals, where they also die in greater numbers. The sex disparity in mortality doubled from high-quality to low-quality hospitals.
A recent analysis found that nearly half of US counties lack a cardiologist, exacerbating rural-urban health disparities. Counties without cardiologists tend to be more rural, socioeconomically disadvantaged, and experience higher cardiovascular mortality rates.
A recent study published in Nature Medicine has shown that pulsed field ablation (PFA) is a safe and effective treatment for patients with atrial fibrillation. The study analyzed over 17,600 patients and found no significant risk of esophageal damage or other complications, increasing confidence in the use of PFA technology.
A large-scale genetic survey found that genes can influence the risk of developing atrial fibrillation. Researchers analyzed over 400,000 individuals and identified six genes whose genetic changes significantly affect a person's risk.
A study by Pusan National University researchers found that repeated item development training enhances faculty members' accuracy in predicting and adjusting item difficulty levels, leading to better educational outcomes. The training improved the quality of MCQ assessments in medical education.
Dr. Harish Manyam has developed a groundbreaking system that addresses potentially dangerous problems associated with traditional pacemakers and defibrillators. The leadless pacemaker, in combination with a novel subcutaneous defibrillator, eliminates the need for lead extraction procedures.
Between 2013 and 2023, private equity firms acquired 41 outpatient cardiology practices, corresponding to 342 clinic sites. The study highlights the critical need to monitor the effects of private equity acquisitions on quality of care and outcomes for patients with cardiovascular disease.
Researchers at the Lewis Katz School of Medicine will investigate how injured heart cells communicate with other cells throughout the body using microvesicles known as exosomes. The study aims to understand how specific molecules, such as microRNAs, facilitate communication pathways between cells in the heart and vasculature.
A Canadian Journal of Cardiology review article finds that plant-based meat alternatives tend to reflect a heart-healthy dietary pattern, improving cholesterol levels and blood pressure. The authors recommend incorporating PBMAs into a healthy diet as an excellent protein source, with options lower in saturated fat and sodium.
Researchers discovered a step-by-step process of calcification in aortic valves, revealing two defense mechanisms: osteopontin and collagen fibers. The study provides new insights into understanding cardiovascular calcification and potential therapeutic applications.
A cohort study of 10,634 participants reveals that childhood risk factors are associated with adult cardiovascular disease. The study highlights the importance of intervening in childhood to reduce the incidence of adult CVD, particularly for body mass index (BMI) and low-density lipoprotein cholesterol.
A survey of 150 million adults in the US suggests that nearly a third of those aged 60 or older are using aspirin for primary prevention of cardiovascular disease without medical advice. The findings highlight the urgent need for physicians to discuss the benefits and risks of aspirin use with their patients.
Women with obesity-related heart failure experienced greater weight loss and improved HF symptoms compared to men. Semaglutide improved HF-related symptoms, physical limitations, exercise function, reduced inflammation, and lower blood pressure across both sexes.
Researchers studied cancer survivors under 25 who had cancer since 1958 and found they were three times more likely to develop cancer later in life. Socioeconomic factors also played a role in survival rates, with lower education levels and foreign backgrounds increasing risk.